HA/LYVE-1 binding regulates cell adhesion, the entry and exit of lymphatic vessels, and activated intracellular signal cascades to enhance lymphangiogenesis and tumour lymphatic metastasis [45,60,187,239]. The gene discussed is LYVE1; the disease is neoplasm.